Bruker Introduces Vutara 352 Super-Resolution Fluorescence Microscope
December 14 2015 - 2:41PM
Business Wire
World’s fastest super-resolution microscope for
cell biology and neuroscience research now also offers quantitative
functionality and multimodal imaging
At the 2015 Cell Biology ASCB Annual Meeting, Bruker (NASDAQ:
BRKR) today announced the release of the first quantitative
super-resolution microscope, the Vutara™ 352. The
Vutara 352 offers speed, imaging depth, and resolution to
deliver significant advantages over competing approaches, now also
adding real-time quantitative capabilities. For the first time,
this represents an entirely new dimension of functionality in
super-resolution microscopy, including the ability to perform
pair-correlation, co-location, cluster, and live-cell analysis with
super resolution.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20151214006237/en/
Bruker Introduces Vutara 352
Super-Resolution Fluorescence Microscope (Photo: Business Wire)
The Vutara 352 is now also compatible with Bruker’s
Opterra multi-point confocal microscope, creating a unique
combination of super-resolution and confocal capabilities, where
both instruments are designed for high-speed imaging. This
enables the visualization of
large-scale, high-resolution structural context in correlation with
super-resolution imaging in even the most challenging live-cell
applications.
“Single molecule localization techniques are unique in that the
images are constructed from discrete, molecular-scale events,”
explained Stephen C. Minne, Ph.D., General Manager of Bruker's
Fluorescence Microscopy Business. “Unlike any other
super-resolution system, the Vutara 352’s new proprietary
algorithms leverage this benefit, enabling researchers to conduct
immediate quantitative analysis on their biology. Only the
Vutara 352 utilizes the highest 3D resolution to quantify
molecular co-location, or the fastest imaging speeds to identify,
track, and quantify fluorescent clusters in live-cells.”
“The Opterra-SR confocal scanner has provided us with a
significant enhancement to our Vutara system,” said Dr. Robert
Hobson from the Department of Biology at the University of Utah.
“We can now perform imaging across a range of modalities, including
confocal imaging and super-resolution imaging. The fast
deconvolution of confocal images provides us with a much clearer
picture of samples of interest at high resolution to complement our
super-resolution imaging. The addition of the quantitative analysis
tools allows us to ask more detailed empirical questions and obtain
more rigorous results.”
About Vutara 352Based on Bruker’s proprietary biplane
technology, Vutara 352 leverages high-performance data
acquisition and image processing capabilities to perform the entire
imaging workflow, from acquisition through localization to
quantitative analysis. Utilizing GPU processing, completion of an
entire workflow cycle can be accomplished in a matter of minutes,
providing a significant enhancement to work throughput. The Opterra
SR confocal scanner option, based on Bruker’s Opterra II Microscope
platform, adds additional imaging functionality to the system,
including real-time deconvolution. In addition to performing
standard fixed preparation and live-cell confocal imaging,
Vutara 352 with the Opterra SR option enables seamless
correlative imaging to provide live, high-resolution imaging for
sample investigation prior to super-resolution imaging, as well as
the capability to combine super-resolution images with confocal
images for contextual information.
About Bruker CorporationFor more than 50 years, Bruker
has enabled scientists to make breakthrough discoveries and develop
new applications that improve the quality of human life. Bruker’s
high-performance scientific research instruments and high-value
analytical solutions enable scientists to explore life and
materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit: http://www.bruker.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151214006237/en/
Bruker CorporationMedia Contact:Bruker Nano
Surfaces DivisionStephen Hopkins, +1 520-741-1044 x1022Marketing
Communicationssteve.hopkins@bruker.comorInvestor
Contact:Joshua Young, +1 978-663-3660 x1479Vice President,
Investor Relationsjoshua.young@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024